Skip to main content

Table 2 Charlson comorbidity indexa and patient comorbiditiesb in total and by presence of psychosocial distress

From: Prognostic factors associated with quality of life in heart failure patients considering the use of the generic EQ-5D-5L™ in primary care: new follow-up results of the observational RECODE-HF study

 

All patients

N = 2354

PSD(+)

N = 630

PSD(−)

N = 1724

P value

Charlson comorbidity index

   

0.600

 0

118 (5.0%)

25 (4.0%)

93 (5.4%)

 

 1–2

1012 (43.0%)

270 (42.9%)

742 (43.0%)

 

 3–4

585 (24.9%)

156 (24.8%)

429 (24.9%)

 

  ≥ 5

217 (9.2%)

64 (10.2%)

153 (8.9%)

 

 No calculation possible

422 (17.9%)

115 (18.3%)

307 (17.8%)

 

Cardiac decompensation or congestive heart failure with dyspnea improving during therapy

1737 (73.8%)

458 (72.7%)

1279 (74.2%)

0.702

Arterial hypertension

1175 (49.9%)

309 (49.0%)

866 (50.2%)

0.611

Chronic ischemic heart disease (also after myocardial infarction, ischemic cardiomyopathy, angina pectoris)

849 (36.1%)

226 (35.9%)

23 (36.1%)

0.906

Dyslipidemia

565 (24.0%)

154 (24.4%)

411 (23.8%)

0.761

Myocardial infarction

523 (22.2%)

135 (21.4%)

388 (22.5%)

0.483

Asthma/chronic pulmonary disease with pulmonary dyspnea

497 (21.1%)

164 (26.0%)

333 (19.3%)

0.002

Has a doctor ever told you that you have heart failure?

   

0.040

 Yes

1725 (73.3%)

485 (77.0%)

1240 (71.9%)

 

 No

443 (18.8%)

9 (15.4%)

346 (20.1%)

 

 I do not know anymore

157 (6.7%)

43 (6.8%)

114 (6.6%)

 

 Missing

29 (1.2%)

5 (0.8%)

24 (1.4%)

 
  1. aAccording to Charlson et al. 1987. bAll comorbidities occurring at prevalence > 20% were listed
  2. PSD Psychosocial distress classified according to hierarchical algorithm; Eisele et al. 2017